IL197621A0 - Use of saccharomyces cerevisiae erg4 mutants for the expression of glucose transporters from mammals - Google Patents

Use of saccharomyces cerevisiae erg4 mutants for the expression of glucose transporters from mammals

Info

Publication number
IL197621A0
IL197621A0 IL197621A IL19762109A IL197621A0 IL 197621 A0 IL197621 A0 IL 197621A0 IL 197621 A IL197621 A IL 197621A IL 19762109 A IL19762109 A IL 19762109A IL 197621 A0 IL197621 A0 IL 197621A0
Authority
IL
Israel
Prior art keywords
erg4
mutants
mammals
expression
saccharomyces cerevisiae
Prior art date
Application number
IL197621A
Other versions
IL197621A (en
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of IL197621A0 publication Critical patent/IL197621A0/en
Publication of IL197621A publication Critical patent/IL197621A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • C12N1/16Yeasts; Culture media therefor
    • C12N1/18Baker's yeast; Brewer's yeast
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Plant Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Botany (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL197621A 2002-09-14 2009-03-16 Saccharomyces cerevisiae erg4 mutants and methods of identifying compounds inhibiting the activity of the corresponding protein of the fgy1 gene IL197621A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10242763A DE10242763A1 (en) 2002-09-14 2002-09-14 New polynucleotide encoding mutant human glucose transporter, useful for identifying antidiabetic agents that can be used to treat diabetes types I or II
PCT/EP2003/009812 WO2004026907A2 (en) 2002-09-14 2003-09-04 Use of saccharomyces cerevisiae erg4 mutants for the expression of glucose transporters from mammals

Publications (2)

Publication Number Publication Date
IL197621A0 true IL197621A0 (en) 2011-08-01
IL197621A IL197621A (en) 2014-01-30

Family

ID=31724774

Family Applications (2)

Application Number Title Priority Date Filing Date
IL167321A IL167321A (en) 2002-09-14 2005-03-08 Polynucleotide comprising a dna sequence encoding a glucose transporter 4, a yeast cell comprising such a polynucleotide and a process for preparing such a yeast cell
IL197621A IL197621A (en) 2002-09-14 2009-03-16 Saccharomyces cerevisiae erg4 mutants and methods of identifying compounds inhibiting the activity of the corresponding protein of the fgy1 gene

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IL167321A IL167321A (en) 2002-09-14 2005-03-08 Polynucleotide comprising a dna sequence encoding a glucose transporter 4, a yeast cell comprising such a polynucleotide and a process for preparing such a yeast cell

Country Status (15)

Country Link
EP (1) EP1539958A2 (en)
JP (1) JP4520854B2 (en)
KR (1) KR101233998B1 (en)
CN (1) CN1694960B (en)
AU (1) AU2003264257B2 (en)
BR (1) BR0314115A (en)
CA (1) CA2498636C (en)
DE (1) DE10242763A1 (en)
HK (1) HK1084401A1 (en)
IL (2) IL167321A (en)
MX (1) MXPA05002816A (en)
NO (1) NO20051795L (en)
RU (1) RU2345136C2 (en)
WO (1) WO2004026907A2 (en)
ZA (1) ZA200501871B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102899328A (en) * 2012-09-28 2013-01-30 南京农业大学 Goat glucose transporter 4 gene as well as recombinant expression vector and application of gene
CN110408616B (en) * 2019-07-09 2021-06-15 中南民族大学 GLUT4 gene knockout sgRNA and A549 cell lines and construction method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5942398A (en) * 1998-02-26 1999-08-24 Millennium Pharmaceuticals, Inc. Nucleic acid molecules encoding glutx and uses thereof
AU5477500A (en) * 1999-06-09 2000-12-28 General Hospital Corporation, The Method of measuring plasma membrane targeting of glut4
DE10106718A1 (en) * 2001-02-14 2002-09-05 Aventis Pharma Gmbh Yeast strain of Saccharomyces cerevisiae with functional expression of a glow transporter

Also Published As

Publication number Publication date
EP1539958A2 (en) 2005-06-15
WO2004026907A2 (en) 2004-04-01
ZA200501871B (en) 2005-10-26
CN1694960A (en) 2005-11-09
AU2003264257B2 (en) 2010-05-20
KR20050056206A (en) 2005-06-14
BR0314115A (en) 2005-07-12
RU2005110955A (en) 2006-01-20
KR101233998B1 (en) 2013-02-18
CA2498636A1 (en) 2004-04-01
CN1694960B (en) 2010-05-12
CA2498636C (en) 2012-04-17
WO2004026907A3 (en) 2004-11-11
MXPA05002816A (en) 2005-05-27
JP4520854B2 (en) 2010-08-11
DE10242763A1 (en) 2004-03-18
RU2345136C2 (en) 2009-01-27
JP2006517088A (en) 2006-07-20
IL197621A (en) 2014-01-30
IL167321A (en) 2013-11-28
HK1084401A1 (en) 2006-07-28
NO20051795L (en) 2005-06-08
AU2003264257A1 (en) 2004-04-08

Similar Documents

Publication Publication Date Title
AU2003302065A1 (en) Solid electrolytic capacitor and method for producing the same
AU2003225782A1 (en) Fluoropolymer blends and multilayer articles
AU2003221377A1 (en) Solid electrolytic capacitor
EP1513538A4 (en) Novel methods for the delivery of polynucleotides to cells
AU2003288230A1 (en) Aircraft door arrangement
AU2003298911A1 (en) Cyclosporins for the treatment of autoimmune diseases
AU2003280836A1 (en) Solid electrolytic capacitor
AU2003282687A8 (en) Glucose transport mutants for production of biomaterial
IL197621A0 (en) Use of saccharomyces cerevisiae erg4 mutants for the expression of glucose transporters from mammals
AU2003215990A1 (en) Saccharomyces cerevisiae mutant
SG104358A1 (en) Double floor structure
AU2003300508A1 (en) Arrangement for measuring the geometry or structure of an object
AU2003252676A1 (en) Preventive for the onset of diabetes
EP1329533B8 (en) Lasernitriding of aluminium-based composites
AUPS038702A0 (en) Construction products with integrated photovoltaics
AU2003277582A1 (en) Fluoropolymer
AU2003235549A8 (en) Double-layer electrochemical capacitor
TW560284U (en) The improvement of the baggage structure
PL349542A1 (en) Novel strain of barm saccharomyces cerevisiae
TW510433U (en) Improved structure for the exit of rolling door
AU2003289294A1 (en) Solid electrolytic capacitor
AU2003236803A1 (en) Conversion layer for bases made of zinc or zinc alloys
AU2003222004A1 (en) Methods of diagnosing the presence of trail
AU2003294947A8 (en) Method for the validated construction of arrays
AU2003242167A1 (en) The telephone with outer covering layer of aluminium alloy

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees